Skip to main content
SpringerLink
Log in

Voorkamerfibrillatie in de eerste lijn

Hoe kan de MyDiagnostick® ondersteuning bieden?

  • artikel
  • Published:
Huisarts Nu

Samenvatting

Voorkamerfibrillatie (VKF) is na extrasystole de meest voorkomende hartritmestoornis.1 Eén zesde van de CVA’s treedt op bij patiënten met VKF.1 Doordat een derde van de VKF-patiënten asymptomatisch is of doordat de symptomen niet onderkend worden, wordt de ziekte vaak pas gediagnosticeerd naar aanleiding van een CVA.1

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  1. Pérula-de-Torres L, Martínez-Adell MA, González-Blanco V, et al. Opportunistic detection of atrial fibrillation in subjects aged 65 years or older in primary care: a randomised clinical trial of efficacy. DOFA-AP study protocol. BMC Family Practice 2012,13:106.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Pisters R, van Oostenbrugge RJ, Knottnerus IL, et al. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace 2010;12:779–84.

    Article  PubMed  Google Scholar 

  3. Boode BS, Heeringa J, Konings KT, et al. NHG-standaard Atriumfibrilleren (eerste herziening). Huisarts Wet 2009:52:646–63.

  4. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263–72.

    Article  PubMed  Google Scholar 

  5. Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation 2013;127:930–7.

    Article  PubMed  Google Scholar 

  6. www.mydiagnostick.com (laatst geraadpleegd op 16 juni 2014)

  7. Tieleman RG, Plantinga Y, Rinkes D, et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace 2014.

  8. Vaes B, Stalpaert S, Tavernier K, et al. The diagnostic accuracy of the MyDiagnostick® to detect atrial fibrillation in primary care. BMC Fam Pract 2014;15:113.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation in the community. The Framingham heart study. Lancet 2009;373:739–45.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840–4. www.framinghamheartstudy.org/risk-functions/atrial-fibrillation/10-year-risk.php

  11. Hendrikx T, Hörnsten R, Rosenqvist M, Sandström H. Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population. BMC Cardiovasc Disord 2013;13:41.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Wilson JMG, Jungner G. The principles and practice of screening for disease. World Health Organization: WHO Public Health papers Geneva; 1968.

    Google Scholar 

  13. Friberg L, Engdahl J, Frykman V et al. Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP). Europace 2013;15:135–40.

    Article  PubMed  Google Scholar 

  14. Wielsel J, Abraham S, Messineo F. Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0). Am J Cardiol 2013.

  15. Lau JK, Lowres N, Neubeck L, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol 2013;165:193–4.

    Article  PubMed  Google Scholar 

  16. Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol 2013;36:328–33.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. KU Leuven, Leuven, Belgium

    Virginie Maes, Klaas Corne, Bert Vaes & Jan Degryse

  2. Insitut de Recherche Santé et Société, Université catholique de Louvain (UCL), Leuven, Belgium

    Bert Vaes & Jan Degryse

Authors
  1. Virginie Maes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klaas Corne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bert Vaes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan Degryse
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Maes V, Corne K, Vaes B, Degryse J. Voorkamerfibrillatie in de eerste lijn: hoe kan de MyDiagnostick® ondersteuning bieden? Huisarts Nu 2016;45:216-9.

De uitgebreide versie van dit artikel vindt u terug op: www.domusmedica.be/huisartsnu

Auteurs

Virginie Maes en Klaas Corne waren huisartsen- in-opleiding ten tijde van het onderzoek, KU Leuven;

Bert Vaes en Jan Degryse zijn verbonden aan het Academisch Centrum Huisartsgeneeskunde, KU Leuven en aan het Institut de Recherche Santé et Société, Université catholique de Louvain (UCL), Brussel.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maes, V., Corne, K., Vaes, B. et al. Voorkamerfibrillatie in de eerste lijn. Huisarts Nu 45, 216–219 (2016). https://doi.org/10.1007/s40954-016-0078-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40954-016-0078-0

Search

Navigation